drugset / Trial / NCT04497012

Iron Supplementation and Intestinal Health

NCT04497012

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a randomized double-blinded study of enteral iron supplementation in Very Low Birth Weight infants. The subjects will be randomized into low dose (2 mg/kg/day) and high dose (6 mg/kg/day) of daily iron supplementation. The primary outcomes are intestinal health including microbiome, inflammation, and barrier function.

Timeline

Start
2020-11-17
Primary completion
2025-03-30
Completion
2025-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iron Sulfate Small molecule 2 mg/kg Other
Comparator Iron Sulfate Small molecule 6 mg/kg Other

Indications